BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL

Rhea-AI Summary

Bio-Techne Corporation (NASDAQ: TECH) announced the appointment of Shane Bohnen as Senior Vice President and General Counsel, effective March 3, 2023. Bohnen succeeds Brenda Furlow, who is retiring after nine years of significant contributions, including establishing the legal and compliance functions and leading corporate sustainability initiatives. Bohnen has over 20 years of legal experience, including his role as Associate General Counsel at Bio-Techne since 2019, where he managed M&A activities and ESG initiatives. Chuck Kummeth, CEO, emphasized Bohnen's extensive knowledge and leadership as vital for the company's growth strategy.

Positive

• Shane Bohnen's extensive experience in legal counsel and M&A activities provides the company with a strong leadership transition.
• Bohnen's background in ESG initiatives aligns with the company's commitment to sustainability.

Negative

• The retirement of Brenda Furlow may create a temporary gap in experience and leadership continuity.

MINNEAPOLIS, Jan. 31, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced Shane Bohnen has been appointed Senior Vice President, General Counsel effective March 3, 2023.  Mr. Bohnen succeeds Brenda Furlow, who will be retiring from the Company after serving as Executive Vice President and General Counsel for the past nine years. Brenda has been and will continue to provide transition support until her March 3, 2023, retirement and will serve in a consulting capacity for special projects going forward.   

Mr. Bohnen has over 20 years of experience as a senior legal advisor, including serving as Bio-Techne's Associate General Counsel since 2019. During his tenure at Bio-Techne, Mr. Bohnen led several initiatives, including commercial support across the entire Bio-Techne enterprise, co-leading recent M&A activities, contributing to the Company's ESG initiatives, including the preparation of the most recent Corporate Sustainability Report, and protecting the enterprise's competitive interests through offensive and defensive litigation. Prior to joining Bio-Techne, Mr. Bohnen spent 10 years in private practice where he developed broad experience in life sciences litigation, practicing in more than sixty U.S. jurisdictions on behalf of life sciences manufacturers and providers, and eventually being elected to the partnership at Bowman & Brooke LLP. Mr. Bohnen also served as in-house corporate counsel at Smiths Medical where he held roles of increasing responsibility including providing conglomerate-wide, global legal support across five distinct enterprises. Additionally, he served briefly as in-house counsel at Resideo where he supported three successful acquisitions, a number of process and culture improvement initiatives and several strategic reorganizations.

"I want to personally thank Brenda for her leadership and significant contributions over the last nine years at Bio-Techne. She established the legal and compliance functions at Bio-Techne, and most recently has been instrumental in leading our corporate sustainability program.  Her legal advice and strategic insight have played an integral role in the Company's success, and I wish her the best in the future," said Chuck Kummeth, President and Chief Executive of Bio-Techne. "Shane has been a trusted legal advisor to the Bio-Techne executive team since joining the Company in 2019. His in-depth knowledge of Bio-Techne and experience in our complex commercial business, management of legal and regulatory risk, oversight of compliance and ethics programs, and corporate governance experience will be essential as we continue to execute our long-term growth strategy."

About Bio-Techne Corporation (NASDAQ:TECH)

Contact: David Clair, Vice President, Investor Relations
david.clair@bio-techne.com
612-656-4416

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-announces-retirement-appointment-of-general-counsel-301729043.html

SOURCE Bio-Techne Corporation

FAQ

Who has been appointed as the new General Counsel at Bio-Techne Corporation?

Shane Bohnen has been appointed as the new Senior Vice President and General Counsel.

When will Shane Bohnen officially start as General Counsel at Bio-Techne?

Shane Bohnen will officially start as General Counsel on March 3, 2023.

What experience does Shane Bohnen bring to Bio-Techne Corporation?

Shane Bohnen has over 20 years of legal experience, including serving as Associate General Counsel at Bio-Techne since 2019.

What role did Brenda Furlow play at Bio-Techne before her retirement?

Brenda Furlow served as Executive Vice President and General Counsel, establishing the legal and compliance functions at the company.

What impact might the management change have on Bio-Techne's growth strategy?

The change in leadership could provide fresh perspectives and maintain the company's focus on long-term growth.